BioSpace News Archive

Press Releases

Lumicell Announces Promising Feasibility Trial Findings Using Pegulicianine in Gastrointestinal Cancer Patients

April 29, 2025
·
3 min read
Press Releases

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

April 29, 2025
·
4 min read
Press Releases

Privo Technologies Expands CLN-004 Clinical Trial Across Leading U.S. Cancer Centers

April 29, 2025
·
2 min read
Press Releases

iTeos Reports First Quarter 2025 Financial Results and Provides Business Updates

April 29, 2025
·
11 min read
Press Releases

Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma

April 29, 2025
·
14 min read
Press Releases

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

April 29, 2025
·
20 min read
Press Releases

AAVantgarde appoints Mr. Rasmus Holm-Jorgensen as Chief Financial Officer

April 29, 2025
·
2 min read
Press Releases

Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025

April 29, 2025
·
3 min read
Press Releases

Ascentage Pharma Presents Results from Five Preclinical Studies at 2025 American Association of Cancer Research (AACR) Annual Meeting, Highlighting Strong Synergistic Effects of Olverembatinib Combined with Lisaftoclax

April 29, 2025
·
13 min read
Press Releases

Ocular Therapeutix™ to Report First Quarter 2025 Financial Results on May 5, 2025

April 29, 2025
·
1 min read